TARGETING SPHINGOSINE KINASE 2 WITH THE NOVEL COMPOUND ABC294640 IN PEDIATRIC SOLID TUMORS

被引：0
|
作者：
Qudeimat, Amr [1 ]
Li, Li [1 ]
Rahamanyian, Mehrdad [1 ]
Prudowsky, Zachary D. [1 ]
Smith, Charles [1 ]
Kraveka, Jacqueline [1 ]
机构：
[1] Med Univ S Carolina, Charleston, SC 29425 USA
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [1] Antiestrogenic Effects of the Novel Sphingosine Kinase-2 Inhibitor ABC294640
    Antoon, James W.
    White, Martin D.
    Meacham, William D.
    Slaughter, Evelyn M.
    Muir, Shannon E.
    Elliott, Steven
    Rhodes, Lyndsay V.
    Ashe, Hasina B.
    Wiese, Thomas E.
    Smith, Charles D.
    Burow, Matthew E.
    Beckman, Barbara S.
    ENDOCRINOLOGY, 2010, 151 (11) : 5124 - 5135
  • [2] Targeting Sphingosine Kinase by ABC294640 against Diffuse Intrinsic Pontine Glioma (DIPG)
    Dai, Lu
    Chen, Jungang
    Lin, Zhen
    Wang, Zhaoxiong
    Qin, Zhiqiang
    Mu, Shengyu
    JOURNAL OF CANCER, 2020, 11 (16): : 4683 - +
  • [3] Targeting Ovarian Cancer and Chemoresistance Through Selective Inhibition of Sphingosine Kinase-2 with ABC294640
    White, Martin D.
    Chan, Lucas
    Antoon, James W.
    Beckman, Barbara S.
    ANTICANCER RESEARCH, 2013, 33 (09) : 3573 - 3579
  • [4] Targeting sphingosine kinase 2 by ABC294640 inhibits human skin squamous cell carcinoma cell growth
    Zhou, Jianbo
    Chen, Jin
    Yu, Huanmiao
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 497 (02) : 535 - 542
  • [5] Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2
    French, Kevin J.
    Zhuang, Yan
    Maines, Lynn W.
    Gao, Peng
    Wang, Wenxue
    Beljanski, Vladimir
    Upson, John J.
    Green, Cecelia L.
    Keller, Staci N.
    Smith, Charles D.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (01): : 129 - 139
  • [6] A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors
    Britten, Carolyn D.
    Garrett-Mayer, Elizabeth
    Chin, Steven H.
    Shirai, Keisuke
    Ogretmen, Besim
    Bentz, Tricia A.
    Brisendine, Alan
    Anderton, Kate
    Cusack, Susan L.
    Maines, Lynn W.
    Zhuang, Yan
    Smith, Charles D.
    Thomas, Melanie B.
    CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4642 - 4650
  • [7] The sphingosine kinase 2 inhibitor ABC294640 inhibits cervical carcinoma cell growth
    Xu, Ling
    Jin, Longmei
    Yang, Baohua
    Wang, Lifeng
    Xia, Ziyin
    Zhang, Qian
    Xu, Jun
    ONCOTARGET, 2018, 9 (02) : 2384 - 2394
  • [8] Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts
    Beljanski, Vladimir
    Lewis, Clayton S.
    Smith, Charles D.
    CANCER BIOLOGY & THERAPY, 2011, 11 (05) : 524 - 534
  • [9] Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo
    Xun, Cai
    Chen, Min-Bin
    Qi, Li
    Zhang Tie-Ning
    Peng, Xue
    Ning, Li
    Chen Zhi-Xiao
    Wang Li-Wei
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
  • [10] Experimental Osteoarthritis in Rats Is Attenuated by ABC294640, a Selective Inhibitor of Sphingosine Kinase-2
    Fitzpatrick, Leo R.
    Green, Cecelia
    Maines, Lynn W.
    Smith, Charles D.
    PHARMACOLOGY, 2011, 87 (3-4) : 135 - 143
12345